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Tho I~ B blockor~, 3 .M E 4031 and 1 .M dofetillde reduced I. ,.,, in SAN 
COIls by 45% and 50%, rospo~wety, and both agents blocked I. ,..,, nearly 
completely =n AVN cells 
Concl~sions, These r0sult$ suggest that I. m SAN coil =s composed ot 
both I~ B and pr0babty I~=, whereas I. *n AVN cellf= iS generated entirely by 
I~ ,  Thts difference in the distnbution el I~ n in nodal cell~ iS important tot 
Un~_ r~a~iflg the modit,cat~n el the automaticity and mtra~onness by th~s 
anf!~!fflylhm~c agent 
Surgical Valve Replacement and Repair 
Wednesday, April 1, 1998, 4:00 pro -5 :00  pm 
Georgia World Congress Center, Room 364W 
4:00 
9~_06~ Impact of Fh~os!~iI-I~tient Mismatch on 
itemodynamk; and C!!nllal Status in ~ ients  With 
an AOd~= Valve 8iopmstheslS 
P Ptbarot JG  Dumesnd M Len~eu.~, P Cartier, J Metras~ L Gdtes 
Durand C~e~,c t-lea;t In.irate O~e#e¢. anO In~t~rur de Ftecherches 
Ctm~ue5 de Montreal Me.treat. Qi~el~:. Carla~a 
The obK'c~ve el thin stu~l~ was to ~e~ermme d pro~the~rs-pat~ent mismatch 
has a detnmental effect on the pahent's hemo(~nam~c and symptomahc 
status and morb~/rly and mo~ah~ A cohort el 392 pahents was followed 
fo~ up to 7 years affe~ =mptantahen o! a ~,%..~ltron~c Intact bK~proslhes=s 
Doppler echocard~sgraphy was ped~med warty In a subgroup at 72 patients 
Eyrie,nee of m~smatch (MM) was defined as an mdexecl valve area 0 85 
~-'~',n~ M~smatch was asso~ated wtth worse I:~toperahve funatmnal class 
IP • 001) independently ot Orner  stgndicant I~ed~ctors uch as age and 
pteot~ratwe f~a l  class but had no s~nd~.ant impact on patient survwal 
{MM: 75 : 4%. no MM 79 ~ 3%. p = 0 59) and valve related rnoroldlty up to 
7 years There was fendenc~ for k~er  tree(~sm from congestive heart fadure 
at  5 years in patients wtth I~1 (85 t 3% versus 93 : 2%. p = 0 05) but Ihls 
d~flerence did not reach statL~t~al s~d~nce m the muh~vanate analysis 
Car~ac m~ex was szrmtar in patients w~th and w~theut MM for up to 3 years 
after operahon I~t dec~e~e~ slc2mftcantty hereafter only m pabents with MM 
( 054 -032Lm~n.,rn~vs 017 : 049L/m=r~m: p=00-4) L~kewtse. the 
mean transprosthetE gradmet which was h~g~er at t ycar a~ter op~ra,~Gn ~r, 
patients w~'h MM t22 : 8 mmHcj versus t5 ~ 7 mmHg. p - 005) mc~ea~ed 
s~ndt~antly ( +6 ~ 6 mmHg vs .  t - t mmHg. p- 0 00 t ) dunng follow-up only 
=n tt~s group In ce;'EILL~On, patients w;th m~stnatcrt have tess symptemet~c 
=mpcm.,ernent and worse hemoch,'namtcs mat continue to detenorate clunng 
tollo~t-up However mechum-term (up to 7 years) pregnosls is relatively 
ca~0d Further stu~.es are necessaW to ~ete;rnlne the longer-term effect5 el 
m~smatCh if any. On mortah~' arYJi morDtdffy 
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;; 906-21 Long Term Results of Homograft Aortic Valve 
Replacement in Patients With Congestive Heart 
Failure 
R G~ocen*Mason. 0 Luncl. V Chandrasekaran. H EIw~daa. R Mazhar, 
M Yacoub The HarehetO AVR Stu~. group Oepartrrrent of Card, elegy and 
Cardtothoraoc surge~ Hareheld Hospital. Harehetd Londo~ UK 
The tmpact el valve type on the long term outcen  e foil.swing aort)c valve 
replacement ~AVR) =n pabents with cong~st~ve heart ~mture |CHF) =s not well 
charaetenzed Homegraffs offer excellent hemeclynamlc fonol=on but need 
replacement after a varying number el years We reviewed 518 patients (aged 
15-85 years) ~, ith aotllc valve d~sease and NYHA class Ill-IV dyspnoea who 
had their m~ba AVR af our hospital over a penod ot 25 years: 381 had a 
homograff (H), ~ a mechanical valve (M) and 47 a stented xenograff IX). 
30-day mo,lalily was 7°° (5% for H) Crude survivals ~ slandard error at 
ten years were 65 '. 2. 52 : 7. and 59 -. 9°° for pabents wdh H. M and X 
respectively M was an independent advurs£ nsk teeter =n a Cox regression 
model, alonj with male sex. preoperatwe pulmonary edema/congestion 
age. cross-c;amp time, and operabon before 1975 Long-term valve-related 
comphcahoa rates varied bohveea valve h,'pes (e.g. thromboembohsm 1 7 : 
0.2, 3.0 : 0.8, and 1 2 : Q7%/pt.vr: anliceagulant-related bleeding 0.2 : 
0 1.2.1 : 0 7 and 0.8 ~. 0 6%/pt.yr: endecarditis 04 r 0 1.0.2 0 1 and 12 
0.7%/pt.yr for H. M and X respectively: all p - 0.05). The rate ot primary bssue 
failure ot H :rod X (3.9 ± 0.3 and 12 z 0.7%/pt.yr. p - 0.05) reflected the age 
of the patients (54 ', 15 vs 70 t 9, p - Q0001) and shorter max. follow-up of 
X (27 vs 14 years). However. the overall incidence of senous eomplicabons 
and cardiac deaths was independently reduced by a homograff AVR. Thus. 
homograft AVR in patients with CHF offers a good long term outcome. 
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........... Reconstruction Pred)~t Durability of Repatr 
E ~ Gros~, R M App!eb~um, AC Galloway, FC Spencer, i Kror~on 
SB CoIvln New YO~k Unlversdv Medial Center, New York, NY USA 
Backgroun~ Doppler echocardlogr;lphy his been ~hown to provide an ~.. 
curate as~essmen! of initial valve anatomy and fon~on after mlfrai valve 
reconstruction We sought 1o pt~ by lransthoRK:lC echocardlography the 
durabdity el both good  and moderate results by echocard~ographlc cntena 
MefhO~. From 1/79 throogh 1/97, 735 patients (pfS) underwent rnmal 
valve reconstruclton Patmnfs were ~enally followed with both clinical ever. 
uabon and fransth0rac=c echocardiograma on a yearly basra Two hundred 
nlneW-hve pie had sequem=al e~h(x:archograph~c follow-up and am the '~ub. 
leCl of this rep oft Time frames analyzecl were within the hrst 6 month intervals 
ancl then yearly M~tral insufficiency (341) was ~Cored 0 (none), 1 (todd), 2 
lmoderate) and 3 (severe) based on color doppler It more than one evalua. 
t=on was obtained within a hme pened, the values were averaged Fdly two 
el th~ pabents had echocar0~ographtc follow.up greater than 3 years 
Resu/~ Results are shown below (' p . 0.0Of by ch=-square test) 
mm4l F~ee~1orr, ~,~c~n MI ~core FolI~w-up 
MI hOtl~ R~op IndlaI I YI ] ¥r5 NYHA ct~ss 
O- I 242256 (97 3~ 0 47 O 84 0 67 I 4 
2 22~25tl}a0%,! i 99 ~0o r 3~ t B 
} 4 14 i2B 6"~1 . d~ 2 O0 2 b 
Conclusions In those pts wdh no or redo MI mmally atler reconstruction 
there was low n~k for reOperalton and follow-up echoc'ardiograms showed 
I~te change over time Tho~e pts w~th severe MI are at ~ greatly mcreasecl 
nsk for re~peration Patients w~th moderate MI also have an elevated nsk 
for reoperat]on: however the degree ot msuflioency does not appear to 
change over time Thus patients wdh moJerafe mltral msuffioency after 
mltral reconstruatton are at tow nsk for progress=on of ch_ .'--~e and maintain 
gOOd tunchonal status 
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i 906-4 i Carpentier-Edwards Perlcardial Bioprosthesis at the 
. . . . . . . .  Mitral Site: Twelve Year Results 
I G~|dsmtlh. GYH Lip ~ R.L Patel. R Nodon Department of 
Car~otnoraoc Surgery. Walsgrave Hosprtat. Cove~ry England ' University 
Depdrtment ot Me.one  Cd~ HospftaL Birmfngham England 
8acMground Per~...mdlat blOproslhe~s provide superior haemodynamic func- 
tion tower rates at thrombc~embehc events and endocardltl5 when compared 
with Porone valves VaNe hie has however been a meier concern with the 
Pers:ardtal vatve~ 
P.Pthc</ To evaluate the clinical performance of the Pencardla} Biopros- 
mesas at the mtfral site we reviewed 90 pahents [29 males, 61 females; mean 
age 60 years (range 22-77 yrsl}, between 1984-1989 There were 82 single 
replacements and 8 double replacements (mltral and aorhc) Pre-operatlvely 
86% at patients were =n NYHA functional class III or IV 47== had atnal fib- 
rlllahon. I~  prevrous mltral valvatomy and 3% prevmus mechanical valve 
replacement wdh rheumatic valve disease the predominant aetmlogy (46%) 
By the closing date to~owup was 98.8% complete, aventgtng 76 months 
with a total cumulatwe fellow-up o| 561 7 patient years. Standard Edmunds 
gutdehnes were used for evaluation 
Results The 30 day hos!mtal mor~ahty was 13% [95% CI 6 3-20 4 I. Valve 
related deaths (early 0. late 5) were 11°~ of the total deaths Late mo~tahty rate 
was 4°° per patient year Patient survival at 12 years was 49 5% (SE 34%) 
Valve related comphcahon rates and freedom from valve related events are 
as follows 
T?ll,vwb.5.~fl 1~,~;,sm I (~ in ~ T~l 83 G',. (SE 3 B) 
Haer~ot{hage I 2 in - 7! 912% (SE 3 2) 
Non-'~lrudural l luf*? L} 9 in 5) 920% tSE 3 3) 
Struc|zJfal fad~,re O ~ ~h ~ 3J 90 9~: ~SE 3 1) 
Fie op*.,rabon 1 I (n = 6) 89 1% ISE 4 1 ) 
At follow-up 935°° survivors were ~n NYHA funCtional class I or II. 
/n conclusron, our expenenco wdh the Carpentmr-Ech'cards PencardTal 
Bloprosthes=s uggests that it continues to prowde sabsfacton/ctin=cal per- 
formance at the mitral positron with low comphcatlon rates 
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